【bordeaux lounge by turquoise photos】Why Is Idexx (IDXX) Down 10.3% Since Last Earnings Report?
It has been about a month since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 10.3% in that time frame,bordeaux lounge by turquoise photos underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Idexx due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
IDEXX Q4 Earnings Top Estimates , Revenues Grow Y/Y
IDEXX Laboratories, Inc
.
posted fourth-quarter 2019 earnings per share of $1.04, reflecting a 6.1% year-over-year rise. The figure surpassed the Zacks Consensus Estimate by 14.3%. Comparable-constant-currency earnings growth was 17%, which excludes the impact of CEO transition charges of 14 cents per share.
For 2019, earnings came in at $4.89, up 14.8% (up 21% at comparable constant currency basis) from the year-ago tally. The figure surpassed the Zacks Consensus Estimate by 2.7%.
Revenues in Detail
Fourth-quarter revenues grew 10.2% year over year to $605.4 million. The metric also beat the Zacks Consensus Estimate by 0.9%. The year-over-year upside was primarily driven by strong global gains in Companion Animal Group (“CAG”) Diagnostics’ recurring revenues.
For 2019, revenues totaled $2.41 billion, up 9% on a reported basis and 10% on an organic basis. The figure surpassed the Zacks Consensus Estimate by 0.4%.
Segmental Analysis
IDEXX derives revenues from four operating segments — CAG; Water; Livestock, Poultry and Dairy (LPD); and Other. In the fourth quarter, CAG revenues rose 11% (up 11% organically) year over year to $529.8 million. The Water segment’s revenues were up 9% (up 10% organically) year over year to $32.87 million. LPD revenues rose 8% (up 10% organically) to $36.7 million. Revenues at the Other segment grew to $6.1 million.
Margins
Gross profit in the fourth quarter rose 10.3% to $331.1 million despite a 10.1% rise in cost of revenues to $274.3 million. Accordingly, gross margin expanded 2 basis points (bps) to 54.7%.
Sales and marketing expenses rose 10.2% to $105.7 million, while general and administrative expenses moved up 26.6% to $74.7 million. Additionally, research and development expenses rose 16.7% to $35.2 million. Operating margin in the quarter contracted 190 bps to 19.1%.
Financial Position
IDEXX exited fiscal 2019 with cash and cash equivalents of $90.3 million compared with $123.8 million at the end of 2018. Net cash provided by operating activities at the end of fiscal 2019 was $459.2 million compared with $400.1 million at the end of 2018.
2020 Outlook
IDEXX has raised its revenue guidance for 2020 to a band of $2.62-2.65 billion, indicating organic and reported revenue growth of 9-10.5%. The Zacks Consensus Estimate for revenues of $2.64 billion falls within the company’s guided range.
Meanwhile, the earnings projection has been raised by 12 cents to the band of $5.42 - $5.58, suggesting annualized growth of 13-16% at CER The Zacks Consensus Estimate for earnings stands at $5.42, within the company’s projected range.
Story continues
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates review.
VGM Scores
Currently, Idexx has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. However, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of this revision has been net zero. It comes with little surprise Idexx has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
View comments
下一篇:Former Walmart CEO says coronavirus will challenge department stores
相关文章:
- GOLO Mobile Inc. Retains Market Maker
- Trump: Falling gas prices are 'tax cut' for US consumers
- What Are Analysts Expecting From Senior plc (LON:SNR) In The Year Ahead?
- BRIEF-Panda Financial's Unit To Transfer Entire Stake In Technology Firm For 218.9 Mln Yuan
- SHAREHOLDER ALERT: TUFN EHTH R: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
- Don’t Sell STEL Holdings Limited (NSE:STEL) Before You Read This
- BRIEF-Great Chinasoft Technology And Partners Plan Financial Technology Buyout Fund Worth 1 Bln Yuan
- Lighting maker Signify fourth-quarter earnings beat, sees steady margins
- How Bassett (BSET) Stock Stands Out in a Strong Industry
- Nordstrom heir Blake Nordstrom dies at 58
相关推荐:
- Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
- Uffizi Gallery Asks Germany to Return Dutch Masterpiece Nazis Stole in World War II
- What Kind Of Shareholder Appears On The Wanbury Limited’s (NSE:WANBURY) Shareholder Register?
- 3 Stocks Peter Lynch Would Love
- Daseke Sees Flatbed Softness Continuing Through First Half Of 2020
- Can Triad Group plc (LON:TRD) Maintain Its Strong Returns?
- Does Cosmo Pharmaceuticals N.V.’s (VTX:COPN) CEO Salary Compare Well With Others?
- Is Transwarranty Finance Limited’s (NSE:TFL) High P/E Ratio A Problem For Investors?
- Exclusive: U.S. sanctions have idled a quarter of Iranian oil rigs
- Copart (CPRT) Gains From Auction Locations Despite High Costs
- Why Is Maximus (MMS) Down 12.8% Since Last Earnings Report?
- Weekly CEO Buys Highlight
- INSIGHT-The religious retreat that sparked India's major coronavirus manhunt
- Is Now An Opportune Moment To Examine Unicaja Banco, S.A. (BME:UNI)?
- ServiceNow (NOW) Set to Acquire AI-Focused Startup Element AI
- Technical Enzymes Market 2028 - Global Insights on Trends, Regulatory Landscape, Value Chain Analysis, Key Stakeholders, Growth Drivers and Future Outlook: Adroit Market Research
- Apollo Endosurgery, Inc. Reports First Quarter 2020 Results
- The Bar Harbor Bankshares (NYSEMKT:BHB) Share Price Is Down 38% So Some Shareholders Are Getting Worried
- India gold discounts at widest in five months as prices surge
- Stocks tumble as coronavirus cases rise rapidly outside China